Quality indicators for diabetes mellitus in the ambulatory setting: Using the Delphi method to inform performance measurement development

Quality and Safety in Health Care

Volumn 17, Issue 5, 2008, Pages 315-317

  Aron, David ^a,b   Pogach, Leonard ^c,d  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Center for Healthcare Knowledge Management   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; BENCHMARKING; CONSENSUS; DELPHI TECHNIQUE; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE;

EID: 61449122150     PISSN: 14753898     EISSN: 14753901     Source Type: Journal    
DOI: 10.1136/qshc.2007.026161     Document Type: Note

References (14)

1. Kelley E, Hurst J. Health Care Quality Indicators Project Conceptual Framework Paper. 23, 1-36. 3-9-2006. Organisation for Economic Co-operation and Development Directorate for Employment, Labour and Social Affairs: Group on Health. OECD Health Working Papers.
2. Pogach L, Englegau M, Aron D. Measuring progress towards achieving A1c goals: pass/fail or partial credit. JAMA 2007;297:520-3.
3. Hayward R. All-or-nothing treatment taregts make bad performance measures. Am J Managed Care 2007;13:126-8.
4. Martirosyan L, Braspenning J, Denig P, et al. Prescribing quality indicators of type 2 diabetes mellitus ambulatory care. Qual Saf Health Care 2008;17:318-23.
5. Campbell S, Shield T, Rogers A, et al. How do stakeholder groups vary in a Delphi technique about primary mental health care and what factors influence their ratings? Qual Health Care 2004;13:428-34.
6. Powell C. The Delphi technique: myths and realities. J Adv Nursing 2003;41:376-82.
7. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147:386-99.
8. Qaseem A, Vijan S, Snow V, et al. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 2007;147:417-22.
9. Moore T, Cohen M, Furberg C. Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007;167:1752-9.
10. Pogach L, Rajan M, Aron D. Aligning performance measurement with clinical epidemiology: comparison of weighted performance measurement and dichotomous threshold for glycemic control in the Veterans Health Administration. Diabetes Care 2006;29:241-6.
11. Kassirer J. On the take: how medicine's complicity with big business can endanger your health. Oxford: Oxford University Press, 2005.
12. Brody H. Hooked: ethics, the medical profesion, and the pharmaceutical industry. Lanham, MD: Rowman & Littlefield, 2007.
13. Greene J. Prescribing by numbers: drugs and the definitions of disease. Baltimore: Johns Hopkins Press, 2007.
14. Burson-Marsteller. National diabetes call to action and blueprint for change. http://www.bursonmarsteller.com/Innovation-and- nsights/Case-Studies/Lists/CaseStudies/DispForm.aspx?ID = 59&nodeName = Healthcare&subTitle = National% 20Diabetes%20Call%20to%20Action%20and% 20Blueprint%20for%20Change (accessed 22 Jul 2008).